News
HC Wainwright & Co. Reiterates Buy on Poseida Therapeutics, Maintains $20 Price Target
22 Apr 24
News, Price Target, Reiteration, Analyst Ratings
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
16 Apr 24
Movers
12 Health Care Stocks Moving In Monday's After-Market Session
15 Apr 24
Movers
Poseida Therapeutics Presents New Phase 1 Data At AACR 2024 Supporting Potential Of P-BCMA-ALLO1 Allogeneic CAR-T Therapy To Benefit Broad Range Of Patients With Multiple Myeloma
8 Apr 24
Biotech, News, General
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
11 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Monday's Intraday Session
11 Mar 24
Movers
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
11 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
HC Wainwright & Co. Reiterates Buy on Poseida Therapeutics, Maintains $20 Price Target
8 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Poseida Therapeutics Q4 EPS $(0.27) Beats $(0.39) Estimate, Sales $25.00M Beat $6.65M Estimate
7 Mar 24
Earnings, News
Press releases
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
18 Apr 24
Press Releases
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
17 Apr 24
Press Releases
Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma
8 Apr 24
Press Releases
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1 Apr 24
Press Releases
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
25 Mar 24
Press Releases
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4 Mar 24
Press Releases